Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Benefits of pain relief on fat...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Benefits of pain relief on fatigue, function, and quality of life when joint inflammation is controlled in patients with RA

Benefits of pain relief on fatigue, function, and quality of life when joint inflammation is controlled in patients with RA

Bibliographic Details
Main Authors: Van De Laar, M, Pope, J, Lee, Y, Fautrel, B, Ikeda, K, Quebe, A, Zhang, X, Gaich, C, De Leonardis, F, Lisse, J, Workman, J, Taylor, P
Format: Conference item
Published: BMJ Publishing Group 2019
  • Holdings
  • Description
  • Similar Items
  • Staff View

Similar Items

  • Effect of baricitinib and adalimumab in reducing pain and improving function in patients with rheumatoid arthritis in low disease activity: exploratory analyses from RA-BEAM
    by: Fautrel, B, et al.
    Published: (2019)
  • Achieving pain control in rheumatoid arthritis with baricitinib or ddalimumab plus methotrexate: Results from the RA-BEAM Trial
    by: Taylor, P, et al.
    Published: (2019)
  • Improved patient-reported outcomes in patients with rheumatoid arthritis who failed adalimumab or placebo treatment and were rescued with baricitinib
    by: Fautrel, B, et al.
    Published: (2017)
  • Assessment of pain improvement in rheumatoid arthritis patients treated with baricitinib, who were inadequate responders to methotrexate and tumor necrosis factor inhibitors
    by: Taylor, P, et al.
    Published: (2019)
  • Comparative effectiveness in pain and haq-di improvement for baricitinib versus adalimumab, tocilizumab, and tofacitinib monotherapies in csdmard-naÏve rheumatoid arthritis patients: a matching-adjusted indirect comparison (MAIC)
    by: Fautrel, B, et al.
    Published: (2018)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs